The results of the present trial provide prospectively defined evidence affirming the hypothesis that long-term, intensive platelet inhibition with ticagrelor reduces ischemic events in patients with prior myocardial infarction
The results of the presenttrial provide prospectively defined evidence affirmingthe hypothesis that long-term, intensiveplatelet inhibition with ticagrelor reduces ischemicevents in patients with prior myocardialinfarction